Arcadia Biosciences (RKDA) Reports Q2 Loss of $2.02

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($2.02), versus ($1.88) reported last year. Revenue for the quarter came in at $436 thousand versus the consensus estimate of $991 thousand.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c